Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Stanford researchers have developed a brain activity scoring system that can predict Alzheimer's risk up to 12 years before symptoms appear — outperforming traditional biomarkers like amyloid-beta and tau. The tool, called the ARC score, also identifies "super agers" whose brains show exceptional resistance to cognitive decline. Scientists hope it could one day guide early interventions like cognitive training or brain stimulation.
Stanford Medicine researchers have uncovered hidden patterns of brain activity that may predict Alzheimer's disease years before memory problems or harmful protein buildup begin — potentially offering an earlier warning system than any existing biomarker. Published in Science Advances, the study introduces the Alzheimer's resilience-vulnerability connectome (ARC) score, derived from resting-state fMRI scans that capture how different brain regions communicate with one another.
The team compared brain scans from 180 "super agers" — adults 75+ with the memory of someone decades younger — against 110 Alzheimer's patients, then applied the resulting scoring system to over 1,300 cognitively healthy adults aged 55–70. The ARC score distinguished the two groups with ~85% accuracy and predicted cognitive decline, amyloid-beta accumulation, and Alzheimer's diagnosis over follow-up periods of up to 12 years.
By the Numbers:
Why it matters: Current Alzheimer's biomarkers like amyloid-beta and tau only become detectable at relatively late disease stages. The ARC score could enable much earlier identification of at-risk individuals — and potentially guide targeted interventions like cognitive training or transcranial magnetic stimulation — while cognitive function is still intact.
